A Randomized Controlled Trial of a Web-based Platform for Cancer Pain Management

Phase 3

Recruiting

• Conditions: Cancer Pain

• Registration Number: NCT06663956
• Lead Sponsor: West China Hospital

Brief Summary

Malignant tumors are one of the major public health problems in China, and cancer pain is a common symptom in tumor patients, affecting the quality of life. In rural areas, cancer pain management is challenging due to insufficient medical resources and limitations in understanding cancer pain. Investigators plan to develop a convenient patient self-reporting applet to help participants report their symptoms to primary care physicians promptly and monitor pain levels and medication in real-time. This project aims to improve the efficiency of cancer pain management, integrate cancer pain into chronic disease management, improve the quality of healthcare services for rural participants, and promote the construction of a healthy China.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-10
• Study Start: 2024-10-21
• Study First Submitted: 2024-10-26
• Study First Submitted QC: 2024-10-28
• Last Update Submitted: 2024-10-28
• Study First Posted: 2024-10-29
• Last Update Posted: 2024-10-31
• Primary Completion: 2026-10-21
• Study Completion: 2026-10-21

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients with tumors that are confirmed by pathological findings.
• Presence of tumor-related pain that is moderate or higher and requires intervention with morphine-based pain medication (++).
• Have a life expectancy of more than 6 months.
• Understand and sign a consent to participate in the study, or if the patient is unable to understand the study, his/her direct caregiver must have a good understanding of the study.

Exclusion Criteria

• Presence of other chronic non-cancer pain/have an unresolved pain-related condition.
• Moderately severe cognitive impairment/cognitive impairment.
• Have schizophrenia or other psychiatric illness.
• Neither the patient nor his/her direct caregiver can understand how to use the Cancer Pain Management applet.
• Being pregnant.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Patient's average pain level (derived from the Brief Pain Scale)	From patient enrollment to 3 months, during which time the applet was used once a week	The Brief Pain Inventory (BPI) is a validated tool for assessing pain intensity and impact on daily life.; The BPI consists of two parts: the first part assesses the intensity of pain using a scale of 0 to 10, where 0 indicates no pain and 10 indicates the worst pain; the second part assesses the impact of pain on various aspects of the patient's life (e.g., mood, work, sleep, and social activities).; The BPI is simple and easy to use, and can help healthcare professionals to quickly obtain quantitative information about pain and monitor the effectiveness of pain management.

Secondary Outcome Measures

Name	Time	Method
Mood and physical state of the patient (derived from the EQ-5D scale)	From patient enrollment to 3 months, during which time the applet was used twice a week	The EQ-5D is a brief scale used to assess an individual's health status and quality of life.The EQ-5D provides a standardized assessment of a patient's health-related quality of life. The scale consists of two parts: the first part is a self-assessment of five dimensions, including mobility, self-care, activities of daily living, pain/discomfort, and anxiety/depression, each of which is scored on a scale ranging from "no problem," "mild problem," "moderate problem," "moderate problem," "moderate problem," "moderate problem," "moderate problem," "moderate problem," "moderate problem," "moderate problem," "moderate problem," and "moderate problem, "Moderate Problems, Severe Problems, and Extreme Problems. The second part is a visual analog scale (VAS) that assesses general health on a scale from 0 (very poor health) to 100 (optimal health).
Burden situation of family members (derived from the Family Support Scale)	From patient enrollment to 3 months, during which time the applet was used twice a week	The Family Support Scale (FSS) is an instrument used to assess the level of support an individual receives in their home environment. The Family Support Scale usually contains items along multiple dimensions, such as emotional support (e.g., care and understanding), material support (e.g., material help), informational support (e.g., advice and guidance), and other relevant family interaction factors. Respondents rate their feelings and experiences of family support, usually on a Likert scale, e.g., from "completely disagree" to "completely agree."
Patient quality of life (derived from the QLQ-C30 core quality of life questionnaire)	From patient enrollment to 3 months, during which time the applet was used twice a week	The C30 scale (EORTC QLQ-C30) is an instrument developed by the European Organization for Research and Treatment of Cancer (EORTC) to assess the quality of life of cancer patients. The scale consists of 30 entries covering the two main dimensions of functioning (e.g., physical, emotional, and social functioning) and symptoms (e.g., pain, fatigue), as well as general health. Patients are scored based on how they have felt over the past week, with scores typically ranging from 0 to 100. Higher scores indicate better quality of life, higher functional status, and less severe symptoms, while lower scores indicate poorer quality of life, limited functioning, and more severe symptoms.The C30 Scale is widely used in cancer research and clinical practice to monitor patients' health status and treatment outcomes.

Trial Locations

Locations (1)

West China Hospital, Sichuan Universit; 🇨🇳 Chengdu, Sichuan, China